Zepp Health Corporation shares surge 61.99% intraday on projected 30% revenue growth for Q2 2025 and strong performance of Amazfit brand.

Zepp Health Corporation surged 61.99% intraday, driven by the company's forecast of a 30% revenue growth for the second quarter of 2025, its first increase in three years, and a strategic shift towards its own brand Amazfit, which saw a 10% year-over-year revenue increase and a 37.3% gross margin in the first quarter of 2025. Additionally, the company's new products, Amazfit Active 2 and Bip 6, have received positive reviews and boosted sales.